Glimepiride Tablet
Product Images NDC 51655-565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 51655-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 565 26 Master Bottle Label Approval Rev A 01 21)

Label (51655 565 26 Master Bottle Label Approval   Rev A 01 21)
This is a description of medication for Glimepiride tablets. The tablets contain 2mg of Glimepiride, with 90 tablets per bottle. The dosage is provided in the package insert. The medication should be stored at controlled room temperature and in the original container to keep children away. The tablets are repackaged by Northwind Pharmaceuticals from the original package from Dr. Reddy's Laboratories Limited in Indianapolis. Identification numbers like GTIN, S/N, and LOT are listed. No other information is available.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.